Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12890209rdf:typepubmed:Citationlld:pubmed
pubmed-article:12890209lifeskim:mentionsumls-concept:C0006836lld:lifeskim
pubmed-article:12890209lifeskim:mentionsumls-concept:C0040261lld:lifeskim
pubmed-article:12890209lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:12890209lifeskim:mentionsumls-concept:C0008976lld:lifeskim
pubmed-article:12890209lifeskim:mentionsumls-concept:C0034656lld:lifeskim
pubmed-article:12890209lifeskim:mentionsumls-concept:C0027342lld:lifeskim
pubmed-article:12890209lifeskim:mentionsumls-concept:C0222001lld:lifeskim
pubmed-article:12890209lifeskim:mentionsumls-concept:C0064113lld:lifeskim
pubmed-article:12890209lifeskim:mentionsumls-concept:C0034107lld:lifeskim
pubmed-article:12890209lifeskim:mentionsumls-concept:C0022902lld:lifeskim
pubmed-article:12890209lifeskim:mentionsumls-concept:C0004083lld:lifeskim
pubmed-article:12890209lifeskim:mentionsumls-concept:C1707455lld:lifeskim
pubmed-article:12890209lifeskim:mentionsumls-concept:C0037633lld:lifeskim
pubmed-article:12890209lifeskim:mentionsumls-concept:C1382100lld:lifeskim
pubmed-article:12890209lifeskim:mentionsumls-concept:C0051736lld:lifeskim
pubmed-article:12890209pubmed:issue1lld:pubmed
pubmed-article:12890209pubmed:dateCreated2003-7-31lld:pubmed
pubmed-article:12890209pubmed:abstractTextTreatment failures and relapses are not uncommon in onychomycosis. Therefore, it is worthwhile to consider the combination of systemic and topical antifungals to improve the cure rates further and to reduce the duration of systemic treatment.lld:pubmed
pubmed-article:12890209pubmed:languageenglld:pubmed
pubmed-article:12890209pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12890209pubmed:citationSubsetIMlld:pubmed
pubmed-article:12890209pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12890209pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12890209pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12890209pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12890209pubmed:statusMEDLINElld:pubmed
pubmed-article:12890209pubmed:monthJullld:pubmed
pubmed-article:12890209pubmed:issn0007-0963lld:pubmed
pubmed-article:12890209pubmed:authorpubmed-author:GeorgalaSSlld:pubmed
pubmed-article:12890209pubmed:authorpubmed-author:Kalogeromitro...lld:pubmed
pubmed-article:12890209pubmed:authorpubmed-author:RigopoulosDDlld:pubmed
pubmed-article:12890209pubmed:authorpubmed-author:PolydorouDDlld:pubmed
pubmed-article:12890209pubmed:authorpubmed-author:IoannidesDDlld:pubmed
pubmed-article:12890209pubmed:authorpubmed-author:FragouliEElld:pubmed
pubmed-article:12890209pubmed:authorpubmed-author:KatsambasA...lld:pubmed
pubmed-article:12890209pubmed:authorpubmed-author:ChristofidouE...lld:pubmed
pubmed-article:12890209pubmed:authorpubmed-author:KatoulisA CAClld:pubmed
pubmed-article:12890209pubmed:authorpubmed-author:BolbasisIIlld:pubmed
pubmed-article:12890209pubmed:authorpubmed-author:KaristinouAAlld:pubmed
pubmed-article:12890209pubmed:authorpubmed-author:BalkouPPlld:pubmed
pubmed-article:12890209pubmed:issnTypePrintlld:pubmed
pubmed-article:12890209pubmed:volume149lld:pubmed
pubmed-article:12890209pubmed:ownerNLMlld:pubmed
pubmed-article:12890209pubmed:authorsCompleteYlld:pubmed
pubmed-article:12890209pubmed:pagination151-6lld:pubmed
pubmed-article:12890209pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:12890209pubmed:meshHeadingpubmed-meshheading:12890209...lld:pubmed
pubmed-article:12890209pubmed:meshHeadingpubmed-meshheading:12890209...lld:pubmed
pubmed-article:12890209pubmed:meshHeadingpubmed-meshheading:12890209...lld:pubmed
pubmed-article:12890209pubmed:meshHeadingpubmed-meshheading:12890209...lld:pubmed
pubmed-article:12890209pubmed:meshHeadingpubmed-meshheading:12890209...lld:pubmed
pubmed-article:12890209pubmed:meshHeadingpubmed-meshheading:12890209...lld:pubmed
pubmed-article:12890209pubmed:meshHeadingpubmed-meshheading:12890209...lld:pubmed
pubmed-article:12890209pubmed:meshHeadingpubmed-meshheading:12890209...lld:pubmed
pubmed-article:12890209pubmed:meshHeadingpubmed-meshheading:12890209...lld:pubmed
pubmed-article:12890209pubmed:meshHeadingpubmed-meshheading:12890209...lld:pubmed
pubmed-article:12890209pubmed:meshHeadingpubmed-meshheading:12890209...lld:pubmed
pubmed-article:12890209pubmed:meshHeadingpubmed-meshheading:12890209...lld:pubmed
pubmed-article:12890209pubmed:meshHeadingpubmed-meshheading:12890209...lld:pubmed
pubmed-article:12890209pubmed:meshHeadingpubmed-meshheading:12890209...lld:pubmed
pubmed-article:12890209pubmed:meshHeadingpubmed-meshheading:12890209...lld:pubmed
pubmed-article:12890209pubmed:meshHeadingpubmed-meshheading:12890209...lld:pubmed
pubmed-article:12890209pubmed:meshHeadingpubmed-meshheading:12890209...lld:pubmed
pubmed-article:12890209pubmed:meshHeadingpubmed-meshheading:12890209...lld:pubmed
pubmed-article:12890209pubmed:year2003lld:pubmed
pubmed-article:12890209pubmed:articleTitleA randomized trial of amorolfine 5% solution nail lacquer in association with itraconazole pulse therapy compared with itraconazole alone in the treatment of Candida fingernail onychomycosis.lld:pubmed
pubmed-article:12890209pubmed:affiliationNational and Kapodistrian University of Athens, Department of Dermatology and Venereology, A.Sygros Hospital, 5 Dragoumi Str., Athens 16121, Greece. eykat@panafonet.grlld:pubmed
pubmed-article:12890209pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12890209pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:12890209pubmed:publicationTypeRandomized Controlled Triallld:pubmed